Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF

BACKGROUND: The age at which heart failure develops varies widely between countries and drug tolerance and outcomes also vary by age. We have examined the efficacy and safety of LCZ696 according to age in the Prospective comparison of angiotensin receptor neprilysin inhibitor with angiotensin conver...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Eur Heart J
Главные авторы: Jhund, Pardeep S., Fu, Michael, Bayram, Edmundo, Chen, Chen-Huan, Negrusz-Kawecka, Marta, Rosenthal, Arvo, Desai, Akshay S., Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael R., McMurray, John J.V., Packer, Milton
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2015
Предметы:
Clinical Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4595742/
https://ncbi.nlm.nih.gov/pubmed/26231885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv330
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы